Login
Register
Submit a Paper
Propose a Special lssue
Open Access
COMMENTARY
Commentary: In search of answers regarding the benefits and harms of short term ADT for intermediate-risk prostate cancer
Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, Virginia, USA
Address correspondence to Dr. Timothy N. Showalter, Dept. of
Radiation Oncology, University of Virginia School of Medicine,
1240 Lee Street, Box 800383, Charlottesville, VA 22908 USA
Canadian Journal of Urology 2017, 24(1), 8663-8663.
Download PDFAbstract
This article has no abstract.Cite This Article
APA Style
Showalter, T.N. (2017). Commentary: In search of answers regarding the benefits and harms of short term ADT for intermediate-risk prostate cancer. Canadian Journal of Urology, 24(1), 8663–8663.
Vancouver Style
Showalter TN. Commentary: In search of answers regarding the benefits and harms of short term ADT for intermediate-risk prostate cancer. Can J Urology. 2017;24(1):8663–8663.
IEEE Style
T.N. Showalter, “Commentary: In search of answers regarding the benefits and harms of short term ADT for intermediate-risk prostate cancer,” Can. J. Urology, vol. 24, no. 1, pp. 8663–8663, 2017.
Copyright © 2017 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
